Time to include the gut microbiota in the hygienic standardisation of laboratory rodents

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 2, 2012, Pages 81-92

  Bleich, André ^a,b   Hansen, Axel Kornerup ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Unfallchirurgische Klinik der Medizinischen   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Animal models; Gut microbiota; Health monitoring; Laboratory rodents

Indexed keywords

PREBIOTIC AGENT;

ACTINOBACTERIA; ANALYTIC METHOD; ANTIBIOTIC THERAPY; ARTHRITIS; ATHEROSCLEROSIS; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTEROIDES; BREAST MILK; CECUM; CONTACT ALLERGY; DIAGNOSTIC PROCEDURE; ESCHERICHIA COLI; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FIRMICUTES; HUMAN; HYGIENE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; IRRITABLE COLON; ISOLATION PROCEDURE; LUPUS ERYTHEMATOSUS; MEDICAL ETHICS; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGAN SIZE; PROTEOBACTERIA; REVIEW; STANDARDIZATION; STRESS; VISCERAL PAIN;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 84857038667     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.12.006     Document Type: Review

References (187)

1. Nicklas W., Baneux P., Boot R., Decelle T., Deeny A., Fumanelli M., et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Laboratory Animals 2002, 36(1):20-42.
2. Hansen A.K. Health status and health monitoring. Handbook of laboratory animal science 2010, 251-306. CRC Press, Boca Raton. 3rd ed. J. Hau, S.J. Schapiro (Eds.).
3. Russell W.M.S., Burch R.L. The principles of humane experimental technique 1959, Methuen & Co Ltd., London.
4. European Economic Community Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. EEC Official Journal 1986, L358:1-28.
5. Council of Europe European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS 123) 1986, Council of Europe, Strassbourg.
6. Institute of Laboratory Animal and Resources Guide for the Care and Use of Laboratory Animals 1996, Commission on Life Sciences. National Research Council. National Academy Press, Washington, DC.
7. Carty A.J. Opportunistic infections of mice and rats: Jacoby and Lindsey revisited. ILAR Journal 2008, 49(3):272-276.
8. Clifford C.B., Watson J. Old enemies, still with us after all these years. ILAR Journal 2008, 49(3):291-302.
9. van de Ven E.M.E.S., Philipse-Bergmann I.M.A., van der Logt J.T.M. Prevalence of naturally occurring viral infections, Mycoplasma pulmonis and Clostridium piliforme in laboratory rodents in Western Europe screened from 2000 to 2003. Laboratory Animals 2006, 40(2):137-143.
10. Mähler M., Köhl W. A serological survey to evaluate contemporary prevalence of viral agents and Mycoplasma pulmonis in laboratory mice and rats in western Europe. Lab Animal 2009, 38(5):161-165.
11. Nicklas W. International harmonization of health monitoring. ILAR Journal 2008, 49(3):338-346.
12. Besselsen D.G., Franklin C.L., Livingston R.S., Riley L.K. Lurking in the shadows: emerging rodent infectious diseases. ILAR Journal 2008, 49(3):277-290.
13. Janus L.M., Smoczek A., Hedrich H.J., Bleich A. Risk assessment of minute virus of mice transmission during rederivation: detection in reproductive organs, gametes, and embryos of mice after in vivo infection. Biology of Reproduction 2009, 81(5):1010-1015.
14. Qin J.J., Li R.Q., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-70.
15. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comparative Medicine 2010, 60(5):336-342.
16. Knight J., Abbott A. Full house. Nature 2002, 417(6891):785-786.
17. Coppa G.V., Bruni S., Morelli L., Soldi S., Gabrielli O. The first prebiotics in humans-human milk oligosaccharides. Journal of Clinical Gastroenterology 2004, 38(6):S80-S83.
18. Yuan J., Wei H., Zeng B.H., Tang H., Li W.X., Zhang Z.X. Impact of neonatal antibiotic treatment on the biodiversity of the murine intestinal Lactobacillus community. Current Microbiology 2010, 60(1):6-11.
19. Schaedler R.W., Orcutt R.P. Gastrointestinal microflora. The mouse in biomedical research 1983, 327-345. Academic Press. H.J. Foster, D.J. Small, J.G. Fox (Eds.).
20. Stecher B., Chaffron S., Kappeli R., Hapfelmeier S., Freedrich S., Weber T.C., et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathogens 2010, 6(1):e1000711.
21. Baker D.E. The commercial production of mice with a specified flora. National Cancer Institute Monograph 1966, 20:161-166.
22. Schaedler R.W., Dubs R., Costello R. Association of germfree mice with bacteria isolated from normal mice. The Journal of Experimental Medicine 1965, 122:77-82.
23. Orcutt R.P., Gianni F.J., Judge R.J. Development of an " Altered Schaedler Flora" for NCI gnotobiotic rodents. Microecology Therapy 1987, 17:59.
24. Dewhirst F.E., Chien C.C., Paster B.J., Ericson R.L., Orcutt R.P., Schauer D.B., et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Applied and Environmental Microbiology 1999, 65(8):3287-3292.
25. Robertson B.R., O'Rourke J.L., Neilan B.A., Vandamme P., On S.L., Fox J.G., et al. Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. International Journal of Systematic and Evolutionary Microbiology 2005, 55(Pt 3):1199-1204.
26. Sarma-Rupavtarm R.B., Ge Z., Schauer D.B., Fox J.G., Polz M.F. Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract. Applied and Environmental Microbiology 2004, 70(5):2791-2800.
27. van der Waaij D. The colonization resistance of the digestive tract in experimental animals and its consequences for infection prevention, acquistion of new bacteria and the prevention of spread of bacteria between cage mates. New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance 1979, 43-53. Excerpta Medica, Amsterdam. D. van der Waaij, J. Verhoef (Eds.).
28. Wensinck F., Ruseler-van Embden J.G. The intestinal flora of colonization-resistant mice. The Journal of Hygiene (London) 1971, 69(3):413-421.
29. Whyte W., Lidwell O.M., Lowbury E.J., Blowers R. Suggested bacteriological standards for air in ultraclean operating rooms. Journal of Hospital Infection 1983, 4(2):133-139.
30. Grice E.A., Kong H.H., Conlan S., Deming C.B., Davis J., Young A.C., et al. Topographical and temporal diversity of the human skin microbiome. Science 2009, 324(5931):1190-1192.
31. Frank D.N., Feazel L.M., Bessesen M.T., Price C.S., Janoff E.N., Pace N.R. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One 2010, 5(5):e10598.
32. Zhang C.H., Zhang M.H., Wang S.Y., Han R.J., Cao Y.F., Hua W.Y., et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. Isme Journal 2010, 4(2):232-241.
33. Vaahtovuo J., Toivanen P., Eerola E. Bacterial composition of murine fecal microflora is indigenous and genetically guided. Fems Microbiology Ecology 2003, 44(1):131-136.
34. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Family relationship of female breeders reduce the systematic inter-individual variation in the gut microbiota of inbred laboratory mice. Laboratory Animals 2010, 44(4):283-289.
35. Wilson K.H., Brown R.S., Andersen G.L., Tsang J., Sartor B. Comparison of fecal biota from specific pathogen free and feral mice. Anaerobe 2006, 12(5-6):249-253.
36. Itoh K., Mitsuoka T., Sudo K., Suzuki K. Comparison of fecal flora of mice based upon different strains and different housing conditions. Zeitschrift fur Versuchstierkunde 1983, 25(3):135-146.
37. Stehr M., Greweling M.C., Tischer S., Singh M., Blocker H., Monner D.A., et al. Charles River altered Schaedler flora (CRASF (R)) remained stable for four years in a mouse colony housed in individually ventilated cages. Laboratory Animals 2009, 43(4):362-370.
38. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65.
39. Pasteur L. Observations rélatives à la Note précédente de M. Declaus. Comptes rendus hebdomadaires des seances del'Academie des sciences 1885, 100:68.
40. Nenchi M. Bemerkung zu einer Bemerkung Pasteurós. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1886, 20:385-388.
41. Metchnikoff E. The nature of man: studies in optimistic philosophy 1903, Heinemann, London.
42. Bleich A., Mähler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and helicobacter-induced gastritis. Pathobiology 2005, 72(6):293-307.
43. Itoh K., Narushima S. Intestinal flora of animal models of human diseases as an environmental factor. Current Issues in Intestinal Microbiology 2005, 6(1):9-15.
44. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134(2):577-594.
45. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biological Psychiatry 2009, 65(3):263-267.
46. Falk P.G., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiology and Molecular Biology Reviews 1998, 62(4):1157-1170.
47. Collins F.M., Carter P.B. Growth of salmonellae in orally infected germfree mice. Infection and Immunity 1978, 21(1):41-47.
48. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biology 2007, 5(10):2177-2189.
49. Bleich A., Sundberg J.P., Smoczek A., von Wasielewski R., de Buhr M.F., Janus L.M., et al. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. International Journal of Experimental Pathology 2008, 89(1):45-54.
50. Freter R., Abrams G.D. Function of various intestinal bacteria in converting germfree mice to normal state. Infection and Immunity 1972, 6(2):119-126.
51. Pleasants J.R., Johnson M.H., Wostmann B.S. Adequacy of chemically defined, water-soluble diet for germfree BALB/c mice through successive generations and litters. Journal of Nutrition 1986, 116(10):1949-1964.
52. Cebra J.J. Influences of microbiota on intestinal immune system development. American Journal of Clinical Nutrition 1999, 69(5):1046S-1051S.
53. Tlaskalova-Hogenova H., Sterzl J., Stepankova R., Dlabac V., Veticka V., Rossmann P., et al. Development of immunological capacity under germfree and conventional conditions. Annals of the New York Academy of Sciences 1983, 409:96-113.
54. Kramer D.R., Cebra J.J. Early appearance of " natural" mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies. Journal of Immunology 1995, 154(5):2051-2062.
55. Bos N.A., Jiang H.Q., Cebra J.J. T cell control of the gut IgA response against commensal bacteria. Gut 2001, 48(6):762-764.
56. Williams A.M., Probert C.S., Stepankova R., Tlaskalova-Hogenova H., Phillips A., Bland P.W. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology 2006, 119(4):470-478.
57. Lauritzen L., Hufeldt M.R., Aasted B., Hansen C.H.F., Midtvedt T., Buschard K., et al. The impact of a germ free perinatal period on the variation in animal models of human inflammatory diseases. Scandinavian Journal of Laboratory Animal Science 2010, 37(1):43-54.
58. Mazmanian S.K., Kasper D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nature Reviews Immunology 2006, 6(11):849-858.
59. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122(1):107-118.
60. Taurog J.D., Richardson J.A., Croft J.T., Simmons W.A., Zhou M., Fernandezsueiro J.L., et al. The germ-free state prevents development of gut and joint inflammatory disease in Hla-B27 transgenic rats. Journal of Experimental Medicine 1994, 180(6):2359-2364.
61. Contractor N.V., Bassiri H., Reya T., Park A.Y., Baumgart D.C., Wasik M.A., et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. Journal of Immunology 1998, 160(1):385-394.
62. Song F., Ito K., Denning T.L., Kuninger D., Papaconstantinou J., Gourley W., et al. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. Journal of Immunology 1999, 162(4):2275-2280.
63. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity 1998, 66(11):5224-5231.
64. Bigazzi P.E. Murine lupus induced by tetramethylpentadecane: an animal model of systemic human autoimmunity. Clinical Immunology 2005, 114(2):97-99.
65. Alam C., Bittoun E., Bhagwat D., Valkonen S., Saari A., et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 2011, 54:1398-1406.
66. Schultz M., Tonkonogy S.L., Sellon R.K., Veltkamp C., Godfrey V.L., Kwon J., et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. American Journal of Physiology 1999, 276(6 Pt 1):G1461-G1472.
67. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(44):15718-15723.
68. Norin E., Midtvedt T. Intestinal microflora functions in laboratory mice claimed to harbor a " normal" intestinal microflora. Is the SPF concept running out of date?. Anaerobe 2010, 16(3):311-313.
69. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Journal of Physiology, London 2004, 558(1):263-275.
70. Amaral F.A., Sachs D., Costa V.V., Fagundes C.T., Cisalpino D., Cunha T.M., et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(6):2193-2197.
71. Brugman S., Klatter F.A., Visser J.T.J., Wildeboer-Veloo A.C.M., Harmsen H.J.M., Rozing J., et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 2006, 49(9):2105-2108.
72. Buschard K., Pedersen C., Hansen S.V., Hageman I., Aaen K., Bendtzen K. Anti-diabetogenic effect of fusidic acid in diabetes prone Bb rats. Autoimmunity 1992, 14(2):101-104.
73. Hansen A.K., Ling F., Kaas A., Funda D.P., Farlov H., Buschard K. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes/Metabolism Research and Reviews 2006, 22(2):220-225.
74. Tabuchi M., Ozaki M., Tamura A., Yamada N., Ishida T., Hosoda M., et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Bioscience Biotechnology and Biochemistry 2003, 67(6):1421-1424.
75. Blumberg R.S., Saubermann L.J., Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Current Opinion in Immunology 1999, 11(6):648-656.
76. Nell S., Suerbaum S., Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nature Reviews Microbiology 2010, 8(8):564-577.
77. Fujiwara D., Wei B., Presley L.L., Brewer S., McPherson M., Lewinski M.A., et al. Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. Journal of Immunology 2008, 180(9):5843-5852.
78. Mottet C., Uhlig H.H., Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. Journal of Immunology 2003, 170(8):3939-3943.
79. Brimnes J., Reimann J., Nissen M., Claesson M. Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. European Journal of Immunology 2001, 31(1):23-31.
80. Rath H.C., Wilson K.H., Sartor R.B. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infection and Immunity 1999, 67(6):2969-2974.
81. Balish E., Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. American Journal of Pathology 2002, 160(6):2253-2257.
82. Kim S.C., Tonkonogy S.L., Albright C.A., Tsang J., Balish E.J., Braun J., et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128(4):891-906.
83. Schultz M., Veltkamp C., Dieleman L.A., Grenther W.B., Wyrick P.B., Tonkonogy S.L., et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflammatory Bowel Diseases 2002, 8(2):71-80.
84. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121(3):580-591.
85. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999, 116(5):1107-1114.
86. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52(7):975-980.
87. Ukena S.N., Singh A., Dringenberg U., Engelhardt R., Seidler U., Hansen W., et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007, 2(12):e1308.
88. Whary M.T., Fox J.G. Detection, eradication, and research implications of Helicobacter infections in laboratory rodents. Laboratory Animal (NY) 2006, 35(7):25-26.
89. Garland C.D., Lee A., Dickson M.R. Segmented filamentous bacteria in the rodent small intestine: their colonization of growing animals and possible role in host resistance to Salmonella. Microbial Ecology 1982, 8(2):181-190.
90. Heczko U., Abe A., Finlay B.B. Segmented filamentous bacteria prevent colonization of enteropathogenic Escherichia coli O103 in rabbits. Journal of Infectious Diseases 2000, 181(3):1027-1033.
91. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139(3):485-498.
92. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31(4):677-689.
93. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031.
94. Marlett J.A., McBurney M.I., Slavin J.L. Position of the American dietetic association: health implications of dietary fiber. Journal of the American Dietetic Association 2002, 102(7):993-1000.
95. Merritt J.C. Metabolic syndrome: soybean foods and, serum lipids. Journal of the National Medical Association 2004, 96(8):1032-1041.
96. Breinholt V., Hossaini A., Svendsen G.W., Brouwer C., Nielsen S.E. Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food and Chemical Toxicology 2000, 38(7):555-564.
97. Tamura M., Ohnishi-Kameyama M., Shinohara K. Lactobacillus gasseri: effects on mouse intestinal flora enzyme activity and isoflavonoids in the caecum and plasma. British Journal of Nutrition 2004, 92(5):771-776.
98. Wang B., Mao Y.K., Diorio C., Wang L., Huizinga J.D., Bienenstock J., et al. Lactobacillus reuteri ingestion and IKCa channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterology and Motility 2010, 22(1). 98-E33.
99. Kamiya T., Wang L., Forsythe P., Goettsche G., Mao Y., Wang Y., et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 2006, 55(2):191-196.
100. Metchnikoff E. Weinberg, Pozerski, Distaso, Bethelot. Roussettes et microbes. Annales de l'Institut Pasteur 1909, 23:937-978.
101. Webster L.T. The intestinal flora in mouse typhoid infection. Journal of Experimental Medicine 1923, 37:21-32.
102. Gordon J.H., Dubos R. The anaerobic bacterial flora of the mouse cecum. Journal of Experimental Medicine 1970, 132(2):251-260.
103. Schaedler R.W., Dubos R., Costello R. The development of the bacterial flora in the gastrointestinal tract of mice. Journal of Experimental Medicine 1965, 122:59-66.
104. Hansen A.K. Handbook of laboratory animal bacteriology 1999, CRC Press, Boca Raton.
105. Hansen A.K. Antibiotic treatment of nude rats and its impact on the aerobic bacterial flora. Laboratory Animals 1995, 29(1):37-44.
106. Dahl K., Kirkeby S., d'Apice A.J.F., Matthiassen S., Hansen A.K. The bacterial flora of alpha-gal knock out mice express the alpha-gal epitope comparable to wild type mice. Transplant Immunology 2005, 14(1):9-16.
107. Hansen A.K. The aerobic bacterial flora of laboratory rats from a Danish breeding centre. Scandinavian Journal of Laboratory Animal Science 1992, 19(2):59-68.
108. Simon G.L., Gorbach S.L. Intestinal flora in health and disease. Gastroenterology 1984, 86(1):174-193.
109. Gustafsson B.E. The physiological importance of the colonic microflora. Scandinavian Journal of Gastroenterology 1982, 17:117-131.
110. Fuentes S., Egert M., Jimenez-Valera M., Ramos-Cormenzana A., Ruiz-Bravo A., Smidt H., et al. Administration of Lactobacillus casei and Lactobacillus plantarum affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure. Research in Microbiology 2008, 159(4):237-243.
111. Fushuku S., Fukuda K. Gender difference in the composition of fecal flora in laboratory mice, as detected by denaturing gradient gel electrophoresis (DGGE). Experimental Animals 2008, 57(5):489-493.
112. Fushuku S., Fukuda K. Inhomogeneity of fecal flora in separately reared laboratory mice, as detected by denaturing gradient gel electrophoresis (DGGE). Experimental Animals 2008, 57(2):95-99.
113. Zoetendal E.G., Collier C.T., Koike S., Mackie R.I., Gaskins H.R. Molecular ecological analysis of the gastrointestinal microbiota: a review. Journal of Nutrition 2004, 134(2):465-472.
114. Vaahtovuo J., Toivanen P., Eerola E. Study of murine faecal microflora by cellular fatty acid analysis; effect of age and mouse strain. Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology 2001, 80(1):35-42.
115. Bibiloni R., Simon M.A., Albright C., Sartor B., Tannock G.W. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Letters in Applied Microbiology 2005, 41(1):45-51.
116. Salzman N.H., de Jong H., Paterson Y., Harmsen H.J.M., Welling G.W., Bos N.A. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology-SGM 2002, 148:3651-3660.
117. Turnbaugh P.J., Baeckhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host & Microbe 2008, 3(4):213-223.
118. Ferreira D.P., Silva V.L., Guimaraes D.A., Coelho C.M., Zauli D.A.G., Farias L.M., et al. Distribution, detection of enterotoxigenic strains and antimicrobial drug susceptibility patterns of bacteroides fragilis group in diarrheic and non-diarrheic feces from Brazilian infants. Brazilian Journal of Microbiology 2010, 41(3):603-611.
119. Sprong R.C., Schonewille A.J., van der Meer R. Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota. Journal of Dairy Science 2010, 93(4):1364-1371.
120. Friswell M.K., Gika H., Stratford I.J., Theodoridis G., Telfer B., Wilson I.D., et al. Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. PLoS One 2010, 5(1).
121. Nones K., Knoch B., Dommels Y.E.M., Paturi G., Butts C., Mcnabb W.C., et al. Multidrug resistance gene deficient (mdr1a(-/-)) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. Journal of Applied Microbiology 2009, 107(2):557-566.
122. Hopkins M.J., Macfarlane G.T., Furrie E., Fite A., Macfarlane S. Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. Fems Microbiology Ecology 2005, 54(1):77-85.
123. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(26):11971-11975.
124. Larsen N., Vogensen F.K., van den Berg F.W.J., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5(2).
125. Hagelin J., Carlsson H.E., Hau J. Increased efficiency in use of laboratory animals. Lancet 1999, 353(9159):1191-1192.
126. Rohde C.M., Wells D.F., Robosky L.C., Manning M.L., Clifford C.B., Reily M.D., et al. Metabonomic evaluation of Schaedler altered microflora rats. Chemical Research in Toxicology 2007, 20(10):1388-1392.
127. Pritchett-Corning K.R., Cosentino J., Clifford C.B. Contemporary prevalence of infectious agents in laboratory mice and rats. Laboratory Animals 2009, 43(2):165-173.
128. Craigie J. 'Bacillus piliformis' (Tyzzer) and Tyzzer's disease of the laboratory mouse. II. Mouse pathogenicity of B. piliformis growth in embryonated eggs. Proceedings of the Royal Society of London. Series B: Biological Sciences 1966, 165(998):61-77.
129. Friis A.S., Ladefoged O. The influence of Bacillus piliformis (Tyzzer) infections on the reliability of pharmacokinetic experiments in mice. Laboratory Animals 1979, 13:257-261.
130. Tyzzer E.E. A fatal disease of the Japanese waltzing mouse caused by a spore-bearing bacillus (Bacillus piliformis N. sp.). Journal of Medical Research 1917, 37:307-338.
131. Van Andel R.A., Franklin C.L., Besch-Williford C.L., Hook R.R., Riley L.K. Role of interleukin-6 in determining the course of murine Tyzzer's disease. Journal of Medical Microbiology 2000, 49(2):171-176.
132. Hoffman S.M., Fleming S.D. Natural Helicobacter infection modulates mouse intestinal muscularis macrophage responses. Cell Biochemistry and Function 2010, 28(8):686-694.
133. Hoffman S.M., Wang H., Pope M.R., Fleming S.D. Helicobacter infection alters MyD88 and Trif signaling in response to intestinal ischemia/reperfusion. Experimental Physiology 2010.
134. Fox J.G., Ge Z., Whary M.T., Erdman S.E., Horwitz B.H. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunology 2010.
135. Hayashimoto N., Ueno M., Takakura A., Ltoh T. A specific polymerase chain reaction based on the gyrB gene sequence and subsequent restriction fragment length polymorphism analysis of Pasteurella pueumotropica isolates from laboratory mice. Journal of the American Association for Laboratory Animal Science 2007, 46(2):54-58.
136. Sasaki H., Kawamoto E., Okiyama E., Ueshiba H., Mikazuki K., Amao H., et al. Molecular typing of Pasteurella pneumotropica isolated from rodents by amplified 16S ribosomal DNA restriction analysis and pulsed-field gel electrophoresis. Microbiology and Immunology 2006, 50(4):265-272.
137. Sasaki H., Kawamoto E., Ueshiba H., Amao H., Sawada T. Phylogenetic relationship of Pasteurella pneumotropica isolates from laboratory rodents based on 16S rDNA sequence. Journal of Veterinary Medical Science 2006, 68(6):639-641.
138. Hayashimoto N., Takakura A., Itoh T. Genetic diversity on 16S rDNA sequence and phylogenic tree analysis in Pasteurella pneumotropica strains isolated from laboratory animals. Current Microbiology 2005, 51(4):239-243.
139. Christensen H., Bisgaard M. Molecular classification and its impact on diagnostics and understanding the phylogeny and epidemiology of selected members of Pasteurellaceae of veterinary importance. Berliner Und Munchener Tierarztliche Wochenschrift 2010, 123(1-2):20-30.
140. Patten C.C., Myles M.H., Franklin C.L., Livingston R.S. Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica. Comparative Medicine 2010, 60(1):18-24.
141. Dickie P., Mounts P., Purcell D., Miller G., Fredrickson T., Chang L.J., et al. Myopathy and spontaneous Pasteurella pneumotropica-induced abscess formation in an HIV-1 transgenic mouse model. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996, 13(2):101-116.
142. Boot R., Vlemminx M.J., Reubsaet F.A.G. Comparison of polymerase chain reaction primer sets for amplification of rodent Pasteurellaceae. Laboratory Animals 2009, 43(4):371-375.
143. Romer J., Bugge T.H., Pyke C., Lund L.R., Flick M.J., Degen J.L., et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Medicine 1996, 2(3):287-292.
144. Pozzilli P., Signore A., Williams A.J.K., Beales P.E. Nod mouse colonies around the world-recent facts and figures. Immunology Today 1993, 14(5):193-196.
145. Matsuzaki T., Nagata Y., Kado S., Uchida K., Kato I., Hashimoto S., et al. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1997, 105(8):643-649.
146. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455(7216):1109-1111.
147. Roesch L.F.W., Lorca G.L., Casella G., Giongo A., Naranjo A., Pionzio A.M., et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME Journal 2009, 3(5):536-548.
148. Hageman I., Buschard K. Antidiabetogenic effect of fusidic acid in diabetes prone BB rats: a sex-dependent organ accumulation of the drug is seen. Pharmacology & Toxicology 2002, 91(3):123-128.
149. Valladares R., Sankar D., Li N., Williams E., Lai K.K., Abdelgeliel A.S., et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010, 5(5).
150. Al-Salami H., Butt G., Fawcett J.P., Tucker I.G., Golocorbin-Kon S., Mikov M. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. European Journal of Drug Metabolism and Pharmacokinetics 2008, 33(2):101-106.
151. Breban M.A., Moreau M.C., Fournier C., Ducluzeau R., Kahn M.F. Influence of the bacterial-flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clinical and Experimental Rheumatology 1993, 11(1):61-64.
152. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75(2):253-261.
153. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75(2):263-274.
154. Madsen K.L., Doyle J.S., Tavernini M.M., Jewell L.D., Rennie R.P., Fedorak R.N. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000, 118(6):1094-1105.
155. Dianda L., Hanby A.M., Wright N.A., Sebesteny A., Hayday A.C., Owen M.J. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. American Journal of Pathology 1997, 150(1):91-97.
156. Axelsson L.G., Midtvedt T., BylundFellenius A.C. The role of intestinal bacteria, bacterial translocation and endotoxin in dextran sodium sulphate-induced colitis in the mouse. Microbial Ecology in Health and Disease 1996, 9(5):225-237.
157. BylundFellenius A.C., Landstrom E., Axelsson L.G., Midtvedt T. Experimental colitis induced by dextran sulfate in normal and germ-free mice. Microbial Ecology in Health and Disease 1994, 7(4):207-215.
158. Kitajima S., Morimoto M., Sagara E., Shimizu C., Ikeda Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Experimental Animals 2001, 50(5):387-395.
159. Pils M.C., Bleich A., Fasnacht N., Bollati-Fogolin M., Schippers A., Rozell B. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell derived Interleukin-10. Inflammatory Bowel Diseases 2011, 17(10):2038-2046.
160. Mileti E., Matteoli G., Iliev I.D., Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009, 4(9).
161. Hakansson A., Branning C., Adawi D., Molin G., Nyman M., Jeppsson B., et al. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scandinavian Journal of Gastroenterology 2009, 44(10):1213-1225.
162. Chen L.L., Wang X.H., Cui Y., Lian G.H., Zhang J., Ouyang C.H., et al. Therapeutic effects of four strains of probiotics on experimental colitis in mice. World Journal of Gastroenterology 2009, 15(3):321-327.
163. Herias M.V., Koninkx J.F.J.G., Vos J.G., in't Veld J.H.J.H., Van Dijk J.E. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. International Journal of Food Microbiology 2005, 103(2):143-155.
164. Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., et al. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clinical and Experimental Immunology 2005, 140(3):417-426.
165. Okada Y., Tsuzuki Y., Miyazaki J., Matsuzaki K., Hokari R., Komoto S., et al. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 2006, 55(5):681-688.
166. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F.L., Linde H.J., et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infection and Immunity 2001, 69(4):2277-2285.
167. Hans W., Scholmerich J., Gross V., Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. European Journal of Gastroenterology & Hepatology 2000, 12(3):267-273.
168. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., et al. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998, 43(1):71-78.
169. Stepankova R., Powrie F., Kofronova O., Kozakova H., Hudcovic T., Hrncir T., et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RB(high) CD4+ T cells. Inflammatory Bowel Diseases 2007, 13(10):1202-1211.
170. Bleich A., Janus L.M., Smoczek A., Westendorf A.M., Strauch U., Mähler M., et al. CpG motifs of bacterial dna exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology 2009, 136(1):278-287.
171. Morrissey P.J., Charrier K. Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells. Research in Immunology 1994, 145(5):357-362.
172. Dieleman L.A., Goerres M.S., Arends A., Sprengers D., Torrice C., Hoentjen F., et al. prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003, 52(3):370-376.
173. Ochoa-Reparaz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 2009, 183(10):6041-6050.
174. Gareau M.G., Jury J., MacQueen G., Sherman P.M., Perdue M.H. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56(11):1522-1528.
175. Kunze W.A., Mao Y.K., Wang B.X., Huizinga J.D., Ma X.L., Forsythe P., et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. Journal of Cellular and Molecular Medicine 2009, 13(8B):2261-2270.
176. Martinez I., Wallace G., Zhang C.M., Legge R., Benson A.K., Carr T.P., et al. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Applied and Environmental Microbiology 2009, 75(12):4175-4184.
177. Tanaka A., Jung K., Benyacoub J., Prioult G., Okamoto N., Ohmori K., et al. Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Experimental Dermatology 2009, 18(12):1022-1027.
178. Watanabe J., Sasajima N., Aramaki A., Sonoyama K. Consumption of fructo-oligosaccharide reduces 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice. British Journal of Nutrition 2008, 100(2):339-346.
179. Chapat L., Chemin K., Dubois B., Bourdet-Sicard R., Kaiserlian D. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. European Journal of Immunology 2004, 34(9):2520-2528.
180. Isolauri E., Majamaa H., Arvola T., Rantala I., Vitamin E., Arvilommi H. Lactobacillus-Casei strain Gg reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993, 105(6):1643-1650.
181. Tsuda M., Hosono A., Yanagibashi T., Kihara-Fujioka M., Hachimura S., Itoh K., et al. Intestinal commensal bacteria promote T cell hyporesponsiveness and down-regulate the serum antibody responses induced by dietary antigen. Immunology Letters 2010, 132(1-2):45-52.
182. Hazebrouck S., Przybylski-Nicaise L., Ah-Leung S., Adel-Patient K., Corthier G., Wal J.M., et al. Allergic sensitization to bovine beta-lactoglobulin: comparison between germ-free and conventional BALB/c mice. International Archives of Allergy and Immunology 2009, 148(1):65-72.
183. Mizutani A., Shaheen V.M., Yoshida H., Akaogi J., Kuroda Y., Nacionales D.C., et al. Pristane-induced autoimmunity in germ-free mice. Clinical Immunology 2005, 114(2):110-118.
184. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB Journal 2008, 22(7):2416-2426.
185. Yadav H., Jain S., Sinha P.R. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. Journal of Dairy Research 2008, 75(2):189-195.
186. Percy D.H., Barthold S.W. Pathology of laboratory rodents & rabbits 2007, Wiley-Blackwell, Ames.
187. Boot R., Oosterhuis A., Thuis H.C. PCR for the detection of Streptobacillus moniliformis. Laboratory Animals 2002, 36(2):200-208.